Medication info
Zimer 10 mg (Memantine Hydrochloride)

Zimer 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
Pale yellow to yellow oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200500928 · Notified 2005.06.01 · Insurance code 649507310

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Day 1~7) Administer 5mg once daily for 7 days. Week 2 (Day 8~14) Administer 10mg once daily for 7 days. Week 3 (Day 15~21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg once daily at least 7 days after administration, following the standard dose escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve memory decline and cognitive function decline caused by Alzheimer's disease. It enhances the patient's ability to perform daily activities and slows the progression of the disease. It is important to adhere to the prescribed method and dosage to ensure safe consumption. This drug is effectively used to manage Alzheimer's symptoms.

How to take

Adult dose

This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Day 1~7) Administer 5mg once daily for 7 days. Week 2 (Day 8~14) Administer 10mg once daily for 7 days. Week 3 (Day 15~21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg once daily at least 7 days after administration, following the standard dose escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This drug should not be used in patients who have allergies to its components or severe liver or kidney dysfunction. Caution is necessary for patients with epilepsy or those who have experienced seizures in the past, as side effects may worsen when used with certain medications. Care should be taken in the use of this drug in situations where urine acidity (pH) changes or in patients with heart disease or uncontrolled hypertension. Side effects such as dizziness, headache, constipation, drowsiness, hypertension may occur, and symptoms such as mental confusion or hallucinations have been reported intermittently. It may interact with other medications, so consult a doctor or pharmacist, especially when taken with specific neurological drugs, antihypertensives, or anticoagulants. Pregnant or breastfeeding women should consult a physician before taking this medication, and it is advisable to avoid use while breastfeeding. Safety and efficacy have not been confirmed for children and adolescents under 18 years of age, so use is not recommended. In case of overdose, symptoms such as confusion, drowsiness, vomiting, or seizures may occur, and it is necessary to visit a medical institution immediately for appropriate treatment. This drug may affect the patient's concentration and reaction speed; therefore, caution is needed when driving or operating machinery. When storing, keep it in a safe place out of reach of children and retain it in the original container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reactions
  • confusion
  • hallucinations
  • psychotic reactions
Show 24 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thromboembolism/thromboembolism
  • respiratory distress
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • lethargy
  • diarrhea
  • agitation
  • aggression
  • delirium
  • unconsciousness
  • diplopia
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is best to store the medication at room temperature between 1°C to 30°C. This helps maintain the drug's effectiveness for a longer time.

Appearance and packaging

Appearance

Pale yellow to yellow oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.